日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sodium valproate drives propionylation-mediated epigenetic reprogramming to enhance mesothelin CAR-T cell therapy in solid tumors

丙戊酸钠驱动丙酰化介导的表观遗传重编程,从而增强间皮素CAR-T细胞疗法在实体瘤中的疗效

Chen, Jiannan; Li, Wenying; Wang, Shuai; Li, Jiayi; Zhao, Lianfeng; Ao, Xudong; Wang, Wenyu; Zhu, Li; Rao, Haipeng; Xu, Shichu; Wen, Mengru; Hu, Zhigang; Pan, Feiyan; He, Lingfeng; Gu, Lili; Fang, Weijia; Xu, Shengjing; Liang, Junqing; Zhao, Peng; Chen, Haoyan; Guo, Zhigang

Efficacy and safety of Telitacicept in IgA nephropathy and its impact on urinary Gd-IgA1: insights from a real-world study

Telitacicept治疗IgA肾病的疗效和安全性及其对尿Gd-IgA1的影响:一项真实世界研究的启示

Li, Hongfen; Li, Wenying; Wang, Fanghao; Xing, Yue; Wu, Zhanfei; Jia, Junya; Liu, Youxia; Yan, Tiekun

Guided Sample Pooling in Human Mass Balance Studies: A Recommended Strategic Decision Framework

人体质量平衡研究中的引导式样本混合:推荐的战略决策框架

Cuyckens, Filip; Li, Wenying; Auclair, Adam M; Cassidy, Kenneth C; Cantalloube, Cathy; Collins, Gary; James, Alexander D; Gibson, Chris; Glaenzel, Ulrike; Huth, Felix; Kang, Ping; Moliner, Patricia; Pedersen, Mette L; Piel, Isabel; Brunetti, Pietro; Schieferstein, Hanno; Wagner, David; Walker, Gregory S; Wang, Shuai; Yue, Qin; Boer, Jason; Khojasteh, Cyrus

Benmelstobart plus anlotinib and chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: A phase 2 study

Benmelstobart联合安罗替尼和化疗治疗HER2阴性晚期胃癌或胃食管交界处腺癌:一项II期研究

Liangyu Bie ,Chen Wei ,Suxia Luo ,Shuailei Dong ,Zhiwei Gu ,Yijie Ma ,Qingxin Xia ,He Zhang ,Jing Li ,Wenying Deng ,Ning Li

Envirotune-CAR-T: a hypoxia-responsive and glutamine-enhanced CAR-T cell therapy for overcoming tumor microenvironment-mediated suppression

Envirotune-CAR-T:一种低氧响应型和谷氨酰胺增强型CAR-T细胞疗法,用于克服肿瘤微环境介导的抑制作用

Li, Wenying; Chen, Jiannan; Li, Jiayi; Wang, Shuai; Chen, Zhengliang; Zhao, Lianfeng; Zhao, Yaoyao; Gu, Lili; Liu, Jiaqi; Zhang, Yan; Yang, Xinhao; Chen, Tianyu; Guo, Zhigang

Super RNA Pol II domains enhance minor ZGA through 3D interaction to ensure the integrity of major transcriptional waves in late-ZGA mammals.

超 RNA Pol II 结构域通过 3D 相互作用增强次要 ZGA,以确保晚期 ZGA 哺乳动物中主要转录波的完整性

Zhang Jingcheng, Li Hengkuan, Li Linmi, Wu Jie, Song Linjie, Liu Xin, Pan Zhangyuan, Zhou Chuan, Li Wenying, Liu Zixiao, Jiao Mei, Hu Mingyang, Dong Zhenyu, Zhang Hexu, Shi Binqiang, Wang Yong, Wang Debao, Carter Benjamin, Zhao Shuhong, Ren Gang, Zhao Yunxia, Zhang Yong

Glutamine-driven metabolic reprogramming promotes CAR-T cell function through mTOR-SREBP2 mediated HMGCS1 upregulation in ovarian cancer

谷氨酰胺驱动的代谢重编程通过 mTOR-SREBP2 介导的 HMGCS1 上调促进卵巢癌中 CAR-T 细胞的功能

Chen, Jiannan; Zhao, Lianfeng; Li, Wenying; Wang, Shuai; Li, Jiayi; Lv, Zhongyuan; Zhao, Yaoyao; Liang, Junqing; Hu, Zhigang; Pan, Feiyan; He, Lingfeng; Gu, Lili; Guo, Zhigang

Targeting GPX2 to disrupt lipid homeostasis and enhance cisplatin sensitivity in diffuse gastric cancer.

靶向 GPX2 以破坏脂质稳态并增强弥漫性胃癌对顺铂的敏感性。

Zhu Yanmei, Ma Yichun, Li Wenying, Pan Yani, Wang Yue, Ye Qiange, Pan Yinya, Xiang Ying, Jiang Ping, Fang Yi, Xu Lei, Liu Na, Liu Gaifang, Wang Zhangding, Xu Guifang

CCR2/CXCR6 enhances tumor infiltration and antitumor efficacy of MSLN CAR-T cells

CCR2/CXCR6增强MSLN CAR-T细胞的肿瘤浸润和抗肿瘤疗效

Zhang, Yan; Zhao, Lianfeng; Liu, Jiaqi; Yang, Xinhao; Chen, Tianyu; Chen, Zhengliang; Li, Wenying; Hu, Zhigang; Pan, Feiyan; Chen, Jiannan; He, Lingfeng; Guo, Zhigang

Molecular Target Identification of Gossypol Against Cervical Cancer Based on Target Fishing Technology

基于靶向捕获技术的棉酚抗宫颈癌分子靶点鉴定

Li, Jinyan; Asat, Rayisa; Li, Wenying; Parhat, Parwen; Ma, Yue; Ma, Yinglan; Li, Min